Unresectable Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Unresectable Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a triple combination of encorafenib, cetuximab, and nivolumab in patients with microsatellite-stabl…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating panitumumab, regorafenib, and TAS-102 in patients with metastatic and/or unresectable RAS wild-type…